News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
400,593 Results
Type
Article (28946)
Company Profile (61)
Press Release (371586)
Multimedia
Podcasts (25)
Webinars (7)
Section
Business (108880)
Career Advice (568)
Deals (17622)
Drug Delivery (52)
Drug Development (49562)
Employer Resources (59)
FDA (12748)
Job Trends (8810)
News (193485)
Policy (20120)
Tag
Academia (1885)
Accelerated approval (3)
Adcomms (10)
Allergies (73)
Alliances (28348)
ALS (58)
Alzheimer's disease (976)
Antibody-drug conjugate (ADC) (51)
Approvals (12811)
Artificial intelligence (190)
Autoimmune disease (10)
Automation (5)
Bankruptcy (156)
Best Places to Work (7186)
BIOSECURE Act (5)
Biosimilars (43)
Biotechnology (42)
Bladder cancer (59)
Brain cancer (18)
Breast cancer (201)
Cancer (1492)
Cardiovascular disease (120)
Career advice (506)
Career pathing (13)
CAR-T (70)
Cell therapy (205)
Cervical cancer (13)
Clinical research (41825)
Collaboration (462)
Compensation (127)
Complete response letters (9)
COVID-19 (1679)
CRISPR (12)
C-suite (141)
Cystic fibrosis (44)
Data (1570)
Decentralized trials (2)
Denatured (17)
Depression (31)
Diabetes (175)
Diagnostics (3848)
Digital health (12)
Diversity (6)
Diversity, equity & inclusion (17)
Drug discovery (60)
Drug pricing (54)
Drug shortages (21)
Duchenne muscular dystrophy (57)
Earnings (38611)
Editorial (20)
Employer branding (8)
Employer resources (55)
Events (54173)
Executive appointments (451)
FDA (13749)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (421)
Gene editing (36)
Generative AI (13)
Gene therapy (134)
GLP-1 (434)
Government (3162)
Grass and pollen (3)
Guidances (38)
Healthcare (12714)
Huntington's disease (12)
IgA nephropathy (17)
Immunology and inflammation (43)
Indications (19)
Infectious disease (1750)
Inflammatory bowel disease (80)
Inflation Reduction Act (4)
Influenza (26)
Intellectual property (52)
Interviews (60)
IPO (7277)
IRA (19)
Job creations (1908)
Job search strategy (460)
Kidney cancer (7)
Labor market (16)
Layoffs (199)
Leadership (5)
Legal (3771)
Liver cancer (59)
Lung cancer (240)
Lymphoma (101)
Machine learning (3)
Management (19)
Manufacturing (113)
MASH (48)
Medical device (13206)
Medtech (13210)
Mergers & acquisitions (10635)
Metabolic disorders (433)
Multiple sclerosis (61)
NASH (16)
Neurodegenerative disease (60)
Neuropsychiatric disorders (9)
Neuroscience (1331)
NextGen: Class of 2025 (4083)
Non-profit (2917)
Now hiring (17)
Obesity (218)
Opinion (86)
Ovarian cancer (52)
Pain (64)
Pancreatic cancer (55)
Parkinson's disease (94)
Partnered (13)
Patents (114)
Patient recruitment (81)
Peanut (37)
People (35682)
Pharmaceutical (17)
Pharmacy benefit managers (11)
Phase I (12011)
Phase II (18154)
Phase III (14900)
Pipeline (696)
Policy (60)
Postmarket research (1714)
Preclinical (3835)
Press Release (20)
Prostate cancer (78)
Psychedelics (17)
Radiopharmaceuticals (207)
Rare diseases (188)
Real estate (3009)
Recruiting (21)
Regulatory (14670)
Reports (21)
Research institute (1717)
Resumes & cover letters (63)
Rett syndrome (2)
RNA editing (3)
RSV (20)
Schizophrenia (51)
Series A (68)
Series B (50)
Service/supplier (3)
Sickle cell disease (21)
Special edition (10)
Spinal muscular atrophy (105)
Sponsored (14)
Startups (2217)
Stomach cancer (9)
Supply chain (39)
Tariffs (11)
The Weekly (8)
Vaccines (440)
Venture capitalists (14)
Weight loss (142)
Women's health (18)
Worklife (4)
Date
Today (97)
Last 7 days (478)
Last 30 days (1503)
Last 365 days (19316)
2025 (6132)
2024 (20710)
2023 (23907)
2022 (32256)
2021 (34412)
2020 (33189)
2019 (29605)
2018 (22709)
2017 (19728)
2016 (18948)
2015 (22163)
2014 (16854)
2013 (14088)
2012 (15204)
2011 (15519)
2010 (14059)
Location
Africa (385)
Alabama (18)
Alaska (2)
Arizona (128)
Arkansas (10)
Asia (25332)
Australia (4084)
California (3159)
Canada (1256)
China (371)
Colorado (169)
Connecticut (174)
Delaware (115)
Europe (51099)
Florida (553)
Georgia (128)
Idaho (38)
Illinois (379)
India (15)
Indiana (226)
Iowa (3)
Japan (123)
Kansas (75)
Kentucky (12)
Louisiana (7)
Maine (27)
Maryland (636)
Massachusetts (2257)
Michigan (110)
Minnesota (280)
Mississippi (2)
Missouri (52)
Montana (18)
Nebraska (18)
Nevada (35)
New Hampshire (62)
New Jersey (1133)
New Mexico (16)
New York (986)
North Carolina (562)
North Dakota (4)
Northern California (1370)
Ohio (138)
Oklahoma (4)
Oregon (25)
Pennsylvania (836)
Puerto Rico (7)
Rhode Island (24)
South America (562)
South Carolina (21)
Southern California (1222)
Tennessee (79)
Texas (574)
United States (13205)
Utah (117)
Virginia (82)
Washington D.C. (39)
Washington State (238)
West Virginia (3)
Wisconsin (45)
400,593 Results for "perimeter medical imaging".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Perimeter Medical Imaging AI to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
April 28, 2025
·
4 min read
Press Releases
Perimeter Medical Imaging AI to Participate in Investor Webinar on February 6th
January 30, 2025
·
4 min read
Lone Star Bio
Perimeter Medical Imaging AI to Host Investor Webcast on June 25
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) – a commercial-stage medical technology company, today announced that it will host a webcast investor presentation on Tuesday, June 25, 2024 at 2:00 PM ET.
June 19, 2024
·
4 min read
Business
Perimeter Medical Imaging AI to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) – a commercial-stage medical technology company – announced it will report its first quarter 2024 financial and operating results after the close of U.S. financial markets on Tuesday, May 14, 2024.
May 9, 2024
·
4 min read
Business
Perimeter Medical Imaging AI Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) – a commercial-stage medical technology company – today reported financial results for the quarter and year ended December 31, 2023 and provided a corporate update.
March 28, 2024
·
8 min read
Press Releases
Perimeter Medical Imaging AI Announces Closing of Non-Brokered Private Placement
September 30, 2024
·
10 min read
Press Releases
Perimeter Medical Imaging AI Announces Additional Closing of Non-Brokered Private Placement
October 10, 2024
·
6 min read
Press Releases
Perimeter Medical Imaging AI Announces Non-Brokered Private Placement
September 10, 2024
·
8 min read
Perimeter Medical Imaging AI Announces Participation at the Upcoming Annual Meeting of the American Society of Breast Surgeons (ASBrS) and Provides Corporate Updates
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) – a commercial-stage medical technology company – announced that it will participate in the upcoming American Society of Breast Surgeons (ASBrS), featuring interactive demos of the S-Series OCT device at the Company’s booth.
April 4, 2024
·
7 min read
Press Releases
Perimeter Medical Imaging AI to Report Third Quarter 2024 Financial Results and Host Conference Call on November 14, 2024
November 8, 2024
·
4 min read
1 of 40,060
Next
